nodes	percent_of_prediction	percent_of_DWPC	metapath
Riluzole—SLC7A11—Rosuvastatin—atherosclerosis	0.547	0.724	CbGbCtD
Riluzole—ABCG2—Ezetimibe—atherosclerosis	0.0717	0.0949	CbGbCtD
Riluzole—ABCG2—Rosuvastatin—atherosclerosis	0.0717	0.0949	CbGbCtD
Riluzole—ABCG2—Pravastatin—atherosclerosis	0.0653	0.0864	CbGbCtD
Riluzole—Ill-defined disorder—Ezetimibe—atherosclerosis	0.00028	0.00152	CcSEcCtD
Riluzole—Anaemia—Ezetimibe—atherosclerosis	0.000279	0.00152	CcSEcCtD
Riluzole—Malaise—Lovastatin—atherosclerosis	0.000278	0.00151	CcSEcCtD
Riluzole—Cardiac disorder—Pravastatin—atherosclerosis	0.000278	0.00151	CcSEcCtD
Riluzole—Muscle spasms—Simvastatin—atherosclerosis	0.000277	0.00151	CcSEcCtD
Riluzole—Vertigo—Lovastatin—atherosclerosis	0.000277	0.0015	CcSEcCtD
Riluzole—Angioedema—Ezetimibe—atherosclerosis	0.000276	0.0015	CcSEcCtD
Riluzole—Angiopathy—Niacin—atherosclerosis	0.000276	0.0015	CcSEcCtD
Riluzole—Leukopenia—Lovastatin—atherosclerosis	0.000276	0.0015	CcSEcCtD
Riluzole—Chills—Niacin—atherosclerosis	0.000273	0.00148	CcSEcCtD
Riluzole—Malaise—Ezetimibe—atherosclerosis	0.000273	0.00148	CcSEcCtD
Riluzole—Arrhythmia—Niacin—atherosclerosis	0.000272	0.00148	CcSEcCtD
Riluzole—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00027	0.00147	CcSEcCtD
Riluzole—Tremor—Simvastatin—atherosclerosis	0.00027	0.00147	CcSEcCtD
Riluzole—Alopecia—Niacin—atherosclerosis	0.000269	0.00146	CcSEcCtD
Riluzole—Chills—Pravastatin—atherosclerosis	0.000269	0.00146	CcSEcCtD
Riluzole—Insomnia—Rosuvastatin—atherosclerosis	0.000268	0.00146	CcSEcCtD
Riluzole—Ill-defined disorder—Simvastatin—atherosclerosis	0.000267	0.00145	CcSEcCtD
Riluzole—Arrhythmia—Pravastatin—atherosclerosis	0.000267	0.00145	CcSEcCtD
Riluzole—Palpitations—Ezetimibe—atherosclerosis	0.000267	0.00145	CcSEcCtD
Riluzole—Paraesthesia—Rosuvastatin—atherosclerosis	0.000267	0.00145	CcSEcCtD
Riluzole—Anaemia—Simvastatin—atherosclerosis	0.000266	0.00145	CcSEcCtD
Riluzole—Malnutrition—Niacin—atherosclerosis	0.000265	0.00144	CcSEcCtD
Riluzole—Alopecia—Pravastatin—atherosclerosis	0.000265	0.00144	CcSEcCtD
Riluzole—Cough—Ezetimibe—atherosclerosis	0.000264	0.00143	CcSEcCtD
Riluzole—Angioedema—Simvastatin—atherosclerosis	0.000263	0.00143	CcSEcCtD
Riluzole—Arthralgia—Lovastatin—atherosclerosis	0.000262	0.00143	CcSEcCtD
Riluzole—Chest pain—Lovastatin—atherosclerosis	0.000262	0.00143	CcSEcCtD
Riluzole—Myalgia—Lovastatin—atherosclerosis	0.000262	0.00143	CcSEcCtD
Riluzole—Anxiety—Lovastatin—atherosclerosis	0.000261	0.00142	CcSEcCtD
Riluzole—Dyspepsia—Rosuvastatin—atherosclerosis	0.000261	0.00142	CcSEcCtD
Riluzole—Hypertension—Ezetimibe—atherosclerosis	0.000261	0.00142	CcSEcCtD
Riluzole—Flatulence—Niacin—atherosclerosis	0.000261	0.00142	CcSEcCtD
Riluzole—Malaise—Simvastatin—atherosclerosis	0.00026	0.00141	CcSEcCtD
Riluzole—Tension—Niacin—atherosclerosis	0.00026	0.00141	CcSEcCtD
Riluzole—Discomfort—Lovastatin—atherosclerosis	0.000259	0.00141	CcSEcCtD
Riluzole—Vertigo—Simvastatin—atherosclerosis	0.000259	0.00141	CcSEcCtD
Riluzole—Leukopenia—Simvastatin—atherosclerosis	0.000258	0.0014	CcSEcCtD
Riluzole—Arthralgia—Ezetimibe—atherosclerosis	0.000257	0.0014	CcSEcCtD
Riluzole—Myalgia—Ezetimibe—atherosclerosis	0.000257	0.0014	CcSEcCtD
Riluzole—Chest pain—Ezetimibe—atherosclerosis	0.000257	0.0014	CcSEcCtD
Riluzole—Nervousness—Niacin—atherosclerosis	0.000257	0.0014	CcSEcCtD
Riluzole—Flatulence—Pravastatin—atherosclerosis	0.000257	0.0014	CcSEcCtD
Riluzole—Dry mouth—Lovastatin—atherosclerosis	0.000257	0.00139	CcSEcCtD
Riluzole—Tension—Pravastatin—atherosclerosis	0.000256	0.00139	CcSEcCtD
Riluzole—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000256	0.00139	CcSEcCtD
Riluzole—Dysgeusia—Pravastatin—atherosclerosis	0.000255	0.00139	CcSEcCtD
Riluzole—Muscle spasms—Niacin—atherosclerosis	0.000254	0.00138	CcSEcCtD
Riluzole—Discomfort—Ezetimibe—atherosclerosis	0.000254	0.00138	CcSEcCtD
Riluzole—Pain—Rosuvastatin—atherosclerosis	0.000254	0.00138	CcSEcCtD
Riluzole—Constipation—Rosuvastatin—atherosclerosis	0.000254	0.00138	CcSEcCtD
Riluzole—Confusional state—Lovastatin—atherosclerosis	0.000254	0.00138	CcSEcCtD
Riluzole—Nervousness—Pravastatin—atherosclerosis	0.000253	0.00138	CcSEcCtD
Riluzole—Dry mouth—Ezetimibe—atherosclerosis	0.000252	0.00137	CcSEcCtD
Riluzole—Anaphylactic shock—Lovastatin—atherosclerosis	0.000252	0.00137	CcSEcCtD
Riluzole—Muscle spasms—Pravastatin—atherosclerosis	0.000251	0.00136	CcSEcCtD
Riluzole—Infection—Lovastatin—atherosclerosis	0.00025	0.00136	CcSEcCtD
Riluzole—Confusional state—Ezetimibe—atherosclerosis	0.000249	0.00135	CcSEcCtD
Riluzole—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000247	0.00134	CcSEcCtD
Riluzole—Thrombocytopenia—Lovastatin—atherosclerosis	0.000246	0.00134	CcSEcCtD
Riluzole—Arthralgia—Simvastatin—atherosclerosis	0.000245	0.00133	CcSEcCtD
Riluzole—Chest pain—Simvastatin—atherosclerosis	0.000245	0.00133	CcSEcCtD
Riluzole—Myalgia—Simvastatin—atherosclerosis	0.000245	0.00133	CcSEcCtD
Riluzole—Infection—Ezetimibe—atherosclerosis	0.000245	0.00133	CcSEcCtD
Riluzole—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000245	0.00133	CcSEcCtD
Riluzole—Anxiety—Simvastatin—atherosclerosis	0.000245	0.00133	CcSEcCtD
Riluzole—Tremor—Pravastatin—atherosclerosis	0.000244	0.00133	CcSEcCtD
Riluzole—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000243	0.00132	CcSEcCtD
Riluzole—Discomfort—Simvastatin—atherosclerosis	0.000242	0.00132	CcSEcCtD
Riluzole—Nervous system disorder—Ezetimibe—atherosclerosis	0.000242	0.00131	CcSEcCtD
Riluzole—Angioedema—Niacin—atherosclerosis	0.000242	0.00131	CcSEcCtD
Riluzole—Ill-defined disorder—Pravastatin—atherosclerosis	0.000242	0.00131	CcSEcCtD
Riluzole—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000242	0.00131	CcSEcCtD
Riluzole—Anaemia—Pravastatin—atherosclerosis	0.000241	0.00131	CcSEcCtD
Riluzole—Anorexia—Lovastatin—atherosclerosis	0.00024	0.0013	CcSEcCtD
Riluzole—Skin disorder—Ezetimibe—atherosclerosis	0.00024	0.0013	CcSEcCtD
Riluzole—Angioedema—Pravastatin—atherosclerosis	0.000238	0.00129	CcSEcCtD
Riluzole—Vertigo—Niacin—atherosclerosis	0.000238	0.00129	CcSEcCtD
Riluzole—Syncope—Niacin—atherosclerosis	0.000237	0.00129	CcSEcCtD
Riluzole—Confusional state—Simvastatin—atherosclerosis	0.000237	0.00129	CcSEcCtD
Riluzole—Leukopenia—Niacin—atherosclerosis	0.000237	0.00129	CcSEcCtD
Riluzole—Urticaria—Rosuvastatin—atherosclerosis	0.000236	0.00128	CcSEcCtD
Riluzole—Anaphylactic shock—Simvastatin—atherosclerosis	0.000235	0.00128	CcSEcCtD
Riluzole—Oedema—Simvastatin—atherosclerosis	0.000235	0.00128	CcSEcCtD
Riluzole—Malaise—Pravastatin—atherosclerosis	0.000235	0.00128	CcSEcCtD
Riluzole—Abdominal pain—Rosuvastatin—atherosclerosis	0.000235	0.00128	CcSEcCtD
Riluzole—Vertigo—Pravastatin—atherosclerosis	0.000234	0.00127	CcSEcCtD
Riluzole—Palpitations—Niacin—atherosclerosis	0.000234	0.00127	CcSEcCtD
Riluzole—Infection—Simvastatin—atherosclerosis	0.000234	0.00127	CcSEcCtD
Riluzole—Leukopenia—Pravastatin—atherosclerosis	0.000233	0.00127	CcSEcCtD
Riluzole—Loss of consciousness—Niacin—atherosclerosis	0.000233	0.00126	CcSEcCtD
Riluzole—Cough—Niacin—atherosclerosis	0.000231	0.00126	CcSEcCtD
Riluzole—Thrombocytopenia—Simvastatin—atherosclerosis	0.00023	0.00125	CcSEcCtD
Riluzole—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000229	0.00125	CcSEcCtD
Riluzole—Insomnia—Lovastatin—atherosclerosis	0.000227	0.00124	CcSEcCtD
Riluzole—Cough—Pravastatin—atherosclerosis	0.000227	0.00124	CcSEcCtD
Riluzole—Paraesthesia—Lovastatin—atherosclerosis	0.000226	0.00123	CcSEcCtD
Riluzole—Myalgia—Niacin—atherosclerosis	0.000225	0.00122	CcSEcCtD
Riluzole—Arthralgia—Niacin—atherosclerosis	0.000225	0.00122	CcSEcCtD
Riluzole—Hypertension—Pravastatin—atherosclerosis	0.000225	0.00122	CcSEcCtD
Riluzole—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000225	0.00122	CcSEcCtD
Riluzole—Anorexia—Simvastatin—atherosclerosis	0.000224	0.00122	CcSEcCtD
Riluzole—Dyspnoea—Lovastatin—atherosclerosis	0.000224	0.00122	CcSEcCtD
Riluzole—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000224	0.00122	CcSEcCtD
Riluzole—Insomnia—Ezetimibe—atherosclerosis	0.000223	0.00121	CcSEcCtD
Riluzole—Myalgia—Pravastatin—atherosclerosis	0.000222	0.00121	CcSEcCtD
Riluzole—Arthralgia—Pravastatin—atherosclerosis	0.000222	0.00121	CcSEcCtD
Riluzole—Chest pain—Pravastatin—atherosclerosis	0.000222	0.00121	CcSEcCtD
Riluzole—Paraesthesia—Ezetimibe—atherosclerosis	0.000222	0.0012	CcSEcCtD
Riluzole—Dyspepsia—Lovastatin—atherosclerosis	0.000221	0.0012	CcSEcCtD
Riluzole—Anxiety—Pravastatin—atherosclerosis	0.000221	0.0012	CcSEcCtD
Riluzole—Dry mouth—Niacin—atherosclerosis	0.00022	0.0012	CcSEcCtD
Riluzole—Dyspnoea—Ezetimibe—atherosclerosis	0.00022	0.0012	CcSEcCtD
Riluzole—Discomfort—Pravastatin—atherosclerosis	0.000219	0.00119	CcSEcCtD
Riluzole—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000219	0.00119	CcSEcCtD
Riluzole—Decreased appetite—Lovastatin—atherosclerosis	0.000219	0.00119	CcSEcCtD
Riluzole—Dyspepsia—Ezetimibe—atherosclerosis	0.000217	0.00118	CcSEcCtD
Riluzole—Fatigue—Lovastatin—atherosclerosis	0.000217	0.00118	CcSEcCtD
Riluzole—Anaphylactic shock—Niacin—atherosclerosis	0.000216	0.00117	CcSEcCtD
Riluzole—Oedema—Niacin—atherosclerosis	0.000216	0.00117	CcSEcCtD
Riluzole—Pain—Lovastatin—atherosclerosis	0.000215	0.00117	CcSEcCtD
Riluzole—Constipation—Lovastatin—atherosclerosis	0.000215	0.00117	CcSEcCtD
Riluzole—Confusional state—Pravastatin—atherosclerosis	0.000214	0.00117	CcSEcCtD
Riluzole—Decreased appetite—Ezetimibe—atherosclerosis	0.000214	0.00117	CcSEcCtD
Riluzole—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000214	0.00116	CcSEcCtD
Riluzole—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000213	0.00116	CcSEcCtD
Riluzole—Asthenia—Rosuvastatin—atherosclerosis	0.000213	0.00116	CcSEcCtD
Riluzole—Insomnia—Simvastatin—atherosclerosis	0.000213	0.00116	CcSEcCtD
Riluzole—Anaphylactic shock—Pravastatin—atherosclerosis	0.000213	0.00116	CcSEcCtD
Riluzole—Oedema—Pravastatin—atherosclerosis	0.000213	0.00116	CcSEcCtD
Riluzole—Fatigue—Ezetimibe—atherosclerosis	0.000213	0.00116	CcSEcCtD
Riluzole—Shock—Niacin—atherosclerosis	0.000213	0.00116	CcSEcCtD
Riluzole—Infection—Pravastatin—atherosclerosis	0.000211	0.00115	CcSEcCtD
Riluzole—Paraesthesia—Simvastatin—atherosclerosis	0.000211	0.00115	CcSEcCtD
Riluzole—Constipation—Ezetimibe—atherosclerosis	0.000211	0.00115	CcSEcCtD
Riluzole—Pain—Ezetimibe—atherosclerosis	0.000211	0.00115	CcSEcCtD
Riluzole—Tachycardia—Niacin—atherosclerosis	0.000211	0.00115	CcSEcCtD
Riluzole—Pruritus—Rosuvastatin—atherosclerosis	0.00021	0.00114	CcSEcCtD
Riluzole—Skin disorder—Niacin—atherosclerosis	0.00021	0.00114	CcSEcCtD
Riluzole—Dyspnoea—Simvastatin—atherosclerosis	0.00021	0.00114	CcSEcCtD
Riluzole—Hyperhidrosis—Niacin—atherosclerosis	0.000209	0.00114	CcSEcCtD
Riluzole—Thrombocytopenia—Pravastatin—atherosclerosis	0.000208	0.00113	CcSEcCtD
Riluzole—Feeling abnormal—Lovastatin—atherosclerosis	0.000207	0.00113	CcSEcCtD
Riluzole—Dyspepsia—Simvastatin—atherosclerosis	0.000207	0.00113	CcSEcCtD
Riluzole—Anorexia—Niacin—atherosclerosis	0.000206	0.00112	CcSEcCtD
Riluzole—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000206	0.00112	CcSEcCtD
Riluzole—Hyperhidrosis—Pravastatin—atherosclerosis	0.000206	0.00112	CcSEcCtD
Riluzole—Decreased appetite—Simvastatin—atherosclerosis	0.000205	0.00111	CcSEcCtD
Riluzole—Feeling abnormal—Ezetimibe—atherosclerosis	0.000203	0.0011	CcSEcCtD
Riluzole—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000203	0.0011	CcSEcCtD
Riluzole—Diarrhoea—Rosuvastatin—atherosclerosis	0.000203	0.0011	CcSEcCtD
Riluzole—Fatigue—Simvastatin—atherosclerosis	0.000203	0.0011	CcSEcCtD
Riluzole—Anorexia—Pravastatin—atherosclerosis	0.000203	0.0011	CcSEcCtD
Riluzole—Hypotension—Niacin—atherosclerosis	0.000202	0.0011	CcSEcCtD
Riluzole—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000202	0.0011	CcSEcCtD
Riluzole—Pain—Simvastatin—atherosclerosis	0.000201	0.00109	CcSEcCtD
Riluzole—Constipation—Simvastatin—atherosclerosis	0.000201	0.00109	CcSEcCtD
Riluzole—Urticaria—Lovastatin—atherosclerosis	0.0002	0.00109	CcSEcCtD
Riluzole—Abdominal pain—Lovastatin—atherosclerosis	0.000199	0.00108	CcSEcCtD
Riluzole—Body temperature increased—Lovastatin—atherosclerosis	0.000199	0.00108	CcSEcCtD
Riluzole—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000197	0.00107	CcSEcCtD
Riluzole—Dizziness—Rosuvastatin—atherosclerosis	0.000196	0.00107	CcSEcCtD
Riluzole—Urticaria—Ezetimibe—atherosclerosis	0.000196	0.00107	CcSEcCtD
Riluzole—Insomnia—Niacin—atherosclerosis	0.000195	0.00106	CcSEcCtD
Riluzole—Body temperature increased—Ezetimibe—atherosclerosis	0.000195	0.00106	CcSEcCtD
Riluzole—Abdominal pain—Ezetimibe—atherosclerosis	0.000195	0.00106	CcSEcCtD
Riluzole—Paraesthesia—Niacin—atherosclerosis	0.000194	0.00105	CcSEcCtD
Riluzole—Feeling abnormal—Simvastatin—atherosclerosis	0.000194	0.00105	CcSEcCtD
Riluzole—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000194	0.00105	CcSEcCtD
Riluzole—Dyspnoea—Niacin—atherosclerosis	0.000193	0.00105	CcSEcCtD
Riluzole—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000192	0.00105	CcSEcCtD
Riluzole—Insomnia—Pravastatin—atherosclerosis	0.000192	0.00105	CcSEcCtD
Riluzole—Somnolence—Niacin—atherosclerosis	0.000192	0.00104	CcSEcCtD
Riluzole—Paraesthesia—Pravastatin—atherosclerosis	0.000191	0.00104	CcSEcCtD
Riluzole—Dyspepsia—Niacin—atherosclerosis	0.00019	0.00103	CcSEcCtD
Riluzole—Dyspnoea—Pravastatin—atherosclerosis	0.00019	0.00103	CcSEcCtD
Riluzole—Decreased appetite—Niacin—atherosclerosis	0.000188	0.00102	CcSEcCtD
Riluzole—Dyspepsia—Pravastatin—atherosclerosis	0.000187	0.00102	CcSEcCtD
Riluzole—Rash—Rosuvastatin—atherosclerosis	0.000187	0.00102	CcSEcCtD
Riluzole—Dermatitis—Rosuvastatin—atherosclerosis	0.000187	0.00102	CcSEcCtD
Riluzole—Urticaria—Simvastatin—atherosclerosis	0.000187	0.00102	CcSEcCtD
Riluzole—Gastrointestinal disorder—Niacin—atherosclerosis	0.000187	0.00101	CcSEcCtD
Riluzole—Body temperature increased—Simvastatin—atherosclerosis	0.000186	0.00101	CcSEcCtD
Riluzole—Abdominal pain—Simvastatin—atherosclerosis	0.000186	0.00101	CcSEcCtD
Riluzole—Headache—Rosuvastatin—atherosclerosis	0.000186	0.00101	CcSEcCtD
Riluzole—Hypersensitivity—Lovastatin—atherosclerosis	0.000185	0.00101	CcSEcCtD
Riluzole—Decreased appetite—Pravastatin—atherosclerosis	0.000185	0.001	CcSEcCtD
Riluzole—Pain—Niacin—atherosclerosis	0.000185	0.001	CcSEcCtD
Riluzole—Fatigue—Pravastatin—atherosclerosis	0.000183	0.000997	CcSEcCtD
Riluzole—Pain—Pravastatin—atherosclerosis	0.000182	0.000989	CcSEcCtD
Riluzole—Constipation—Pravastatin—atherosclerosis	0.000182	0.000989	CcSEcCtD
Riluzole—Hypersensitivity—Ezetimibe—atherosclerosis	0.000182	0.000988	CcSEcCtD
Riluzole—Asthenia—Lovastatin—atherosclerosis	0.00018	0.000981	CcSEcCtD
Riluzole—Pruritus—Lovastatin—atherosclerosis	0.000178	0.000967	CcSEcCtD
Riluzole—Asthenia—Ezetimibe—atherosclerosis	0.000177	0.000962	CcSEcCtD
Riluzole—Gastrointestinal pain—Niacin—atherosclerosis	0.000177	0.00096	CcSEcCtD
Riluzole—Nausea—Rosuvastatin—atherosclerosis	0.000176	0.000958	CcSEcCtD
Riluzole—Feeling abnormal—Pravastatin—atherosclerosis	0.000175	0.000953	CcSEcCtD
Riluzole—Pruritus—Ezetimibe—atherosclerosis	0.000175	0.000949	CcSEcCtD
Riluzole—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000174	0.000945	CcSEcCtD
Riluzole—Hypersensitivity—Simvastatin—atherosclerosis	0.000173	0.000942	CcSEcCtD
Riluzole—Diarrhoea—Lovastatin—atherosclerosis	0.000172	0.000935	CcSEcCtD
Riluzole—Urticaria—Niacin—atherosclerosis	0.000172	0.000933	CcSEcCtD
Riluzole—Abdominal pain—Niacin—atherosclerosis	0.000171	0.000928	CcSEcCtD
Riluzole—Body temperature increased—Niacin—atherosclerosis	0.000171	0.000928	CcSEcCtD
Riluzole—Urticaria—Pravastatin—atherosclerosis	0.000169	0.000918	CcSEcCtD
Riluzole—Asthenia—Simvastatin—atherosclerosis	0.000169	0.000917	CcSEcCtD
Riluzole—Diarrhoea—Ezetimibe—atherosclerosis	0.000169	0.000917	CcSEcCtD
Riluzole—Abdominal pain—Pravastatin—atherosclerosis	0.000168	0.000914	CcSEcCtD
Riluzole—Body temperature increased—Pravastatin—atherosclerosis	0.000168	0.000914	CcSEcCtD
Riluzole—Pruritus—Simvastatin—atherosclerosis	0.000166	0.000905	CcSEcCtD
Riluzole—Dizziness—Lovastatin—atherosclerosis	0.000166	0.000904	CcSEcCtD
Riluzole—Dizziness—Ezetimibe—atherosclerosis	0.000163	0.000887	CcSEcCtD
Riluzole—Diarrhoea—Simvastatin—atherosclerosis	0.000161	0.000875	CcSEcCtD
Riluzole—Vomiting—Lovastatin—atherosclerosis	0.00016	0.000869	CcSEcCtD
Riluzole—Hypersensitivity—Niacin—atherosclerosis	0.000159	0.000865	CcSEcCtD
Riluzole—Rash—Lovastatin—atherosclerosis	0.000159	0.000862	CcSEcCtD
Riluzole—Dermatitis—Lovastatin—atherosclerosis	0.000158	0.000861	CcSEcCtD
Riluzole—Headache—Lovastatin—atherosclerosis	0.000158	0.000856	CcSEcCtD
Riluzole—Vomiting—Ezetimibe—atherosclerosis	0.000157	0.000853	CcSEcCtD
Riluzole—Hypersensitivity—Pravastatin—atherosclerosis	0.000157	0.000852	CcSEcCtD
Riluzole—Dizziness—Simvastatin—atherosclerosis	0.000156	0.000846	CcSEcCtD
Riluzole—Rash—Ezetimibe—atherosclerosis	0.000156	0.000845	CcSEcCtD
Riluzole—Dermatitis—Ezetimibe—atherosclerosis	0.000155	0.000845	CcSEcCtD
Riluzole—Asthenia—Niacin—atherosclerosis	0.000155	0.000842	CcSEcCtD
Riluzole—Headache—Ezetimibe—atherosclerosis	0.000155	0.00084	CcSEcCtD
Riluzole—Pruritus—Niacin—atherosclerosis	0.000153	0.000831	CcSEcCtD
Riluzole—Asthenia—Pravastatin—atherosclerosis	0.000153	0.000829	CcSEcCtD
Riluzole—Pruritus—Pravastatin—atherosclerosis	0.00015	0.000818	CcSEcCtD
Riluzole—Vomiting—Simvastatin—atherosclerosis	0.00015	0.000813	CcSEcCtD
Riluzole—Nausea—Lovastatin—atherosclerosis	0.000149	0.000812	CcSEcCtD
Riluzole—Rash—Simvastatin—atherosclerosis	0.000148	0.000806	CcSEcCtD
Riluzole—Dermatitis—Simvastatin—atherosclerosis	0.000148	0.000805	CcSEcCtD
Riluzole—Diarrhoea—Niacin—atherosclerosis	0.000148	0.000803	CcSEcCtD
Riluzole—Headache—Simvastatin—atherosclerosis	0.000147	0.000801	CcSEcCtD
Riluzole—Nausea—Ezetimibe—atherosclerosis	0.000147	0.000796	CcSEcCtD
Riluzole—Diarrhoea—Pravastatin—atherosclerosis	0.000146	0.000791	CcSEcCtD
Riluzole—Dizziness—Niacin—atherosclerosis	0.000143	0.000776	CcSEcCtD
Riluzole—Dizziness—Pravastatin—atherosclerosis	0.000141	0.000764	CcSEcCtD
Riluzole—Nausea—Simvastatin—atherosclerosis	0.00014	0.00076	CcSEcCtD
Riluzole—Vomiting—Niacin—atherosclerosis	0.000137	0.000747	CcSEcCtD
Riluzole—Rash—Niacin—atherosclerosis	0.000136	0.00074	CcSEcCtD
Riluzole—Dermatitis—Niacin—atherosclerosis	0.000136	0.00074	CcSEcCtD
Riluzole—Headache—Niacin—atherosclerosis	0.000135	0.000736	CcSEcCtD
Riluzole—Vomiting—Pravastatin—atherosclerosis	0.000135	0.000735	CcSEcCtD
Riluzole—Rash—Pravastatin—atherosclerosis	0.000134	0.000729	CcSEcCtD
Riluzole—Dermatitis—Pravastatin—atherosclerosis	0.000134	0.000728	CcSEcCtD
Riluzole—Headache—Pravastatin—atherosclerosis	0.000133	0.000724	CcSEcCtD
Riluzole—Nausea—Niacin—atherosclerosis	0.000128	0.000697	CcSEcCtD
Riluzole—Nausea—Pravastatin—atherosclerosis	0.000126	0.000687	CcSEcCtD
Riluzole—SCN5A—Developmental Biology—PPARA—atherosclerosis	5.74e-05	0.000951	CbGpPWpGaD
Riluzole—ABCG2—HIF-1-alpha transcription factor network—AKT1—atherosclerosis	5.74e-05	0.000951	CbGpPWpGaD
Riluzole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—atherosclerosis	5.73e-05	0.00095	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—atherosclerosis	5.71e-05	0.000946	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	5.48e-05	0.000908	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—LEP—atherosclerosis	5.45e-05	0.000903	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—ABCG8—atherosclerosis	5.44e-05	0.000902	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—LTA4H—atherosclerosis	5.44e-05	0.000902	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—CETP—atherosclerosis	5.33e-05	0.000884	CbGpPWpGaD
Riluzole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARA—atherosclerosis	5.33e-05	0.000883	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—ABCG8—atherosclerosis	5.27e-05	0.000874	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—LTA4H—atherosclerosis	5.27e-05	0.000874	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	5.19e-05	0.000861	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	5.19e-05	0.000861	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	5.19e-05	0.000861	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	5.19e-05	0.000861	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—atherosclerosis	5.18e-05	0.000859	CbGpPWpGaD
Riluzole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—atherosclerosis	5.16e-05	0.000855	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	5.13e-05	0.00085	CbGpPWpGaD
Riluzole—SCN5A—SIDS Susceptibility Pathways—IL6—atherosclerosis	5.11e-05	0.000847	CbGpPWpGaD
Riluzole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—APOA1—atherosclerosis	5e-05	0.000828	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	4.95e-05	0.000821	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—VEGFA—atherosclerosis	4.87e-05	0.000807	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—atherosclerosis	4.76e-05	0.000788	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	4.75e-05	0.000787	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—PPARG—atherosclerosis	4.74e-05	0.000786	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—PLAT—atherosclerosis	4.7e-05	0.000779	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—INS—atherosclerosis	4.65e-05	0.000771	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—MAPK3—atherosclerosis	4.6e-05	0.000763	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—MMP9—atherosclerosis	4.59e-05	0.00076	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	4.57e-05	0.000758	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—LDLRAP1—atherosclerosis	4.52e-05	0.000749	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—TGFB1—atherosclerosis	4.47e-05	0.00074	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—atherosclerosis	4.44e-05	0.000736	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—TNF—atherosclerosis	4.44e-05	0.000736	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	4.41e-05	0.000732	CbGpPWpGaD
Riluzole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—atherosclerosis	4.4e-05	0.00073	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—MMP2—atherosclerosis	4.36e-05	0.000722	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—ABCG1—atherosclerosis	4.3e-05	0.000713	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PLTP—atherosclerosis	4.25e-05	0.000704	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—ABCG1—atherosclerosis	4.17e-05	0.000691	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—VEGFA—atherosclerosis	4.12e-05	0.000683	CbGpPWpGaD
Riluzole—CYP1A2—Biological oxidations—GSTM1—atherosclerosis	4.06e-05	0.000673	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—LCAT—atherosclerosis	4.04e-05	0.00067	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—FABP4—atherosclerosis	4.04e-05	0.00067	CbGpPWpGaD
Riluzole—CYP1A2—Metapathway biotransformation—GSTM1—atherosclerosis	4.01e-05	0.000664	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—PLG—atherosclerosis	4e-05	0.000662	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—APOA4—atherosclerosis	3.97e-05	0.000658	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	3.93e-05	0.000652	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	3.92e-05	0.000649	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	3.92e-05	0.000649	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	3.91e-05	0.000648	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—CYP7A1—atherosclerosis	3.9e-05	0.000646	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—MAPK3—atherosclerosis	3.9e-05	0.000646	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	3.89e-05	0.000644	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	3.85e-05	0.000637	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	3.8e-05	0.000629	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	3.78e-05	0.000626	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—HMOX1—atherosclerosis	3.69e-05	0.000611	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—LTA4H—atherosclerosis	3.68e-05	0.00061	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—ABCG8—atherosclerosis	3.68e-05	0.00061	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	3.64e-05	0.000603	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—CYP27A1—atherosclerosis	3.6e-05	0.000597	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—APOB—atherosclerosis	3.53e-05	0.000585	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	3.49e-05	0.000579	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	3.43e-05	0.000569	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—APOA2—atherosclerosis	3.42e-05	0.000566	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—ALOX15—atherosclerosis	3.42e-05	0.000566	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—ALOX5AP—atherosclerosis	3.42e-05	0.000566	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—PLA2G2A—atherosclerosis	3.42e-05	0.000566	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—ABCG5—atherosclerosis	3.37e-05	0.000559	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	3.31e-05	0.000549	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	3.31e-05	0.000549	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	3.31e-05	0.000549	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	3.31e-05	0.000549	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—MMP9—atherosclerosis	3.27e-05	0.000543	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	3.27e-05	0.000542	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—LPA—atherosclerosis	3.26e-05	0.00054	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—NFKB1—atherosclerosis	3.24e-05	0.000537	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	3.16e-05	0.000523	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—BGN—atherosclerosis	3.16e-05	0.000523	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—APOA5—atherosclerosis	3.12e-05	0.000518	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—AKT1—atherosclerosis	3.11e-05	0.000515	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	3.06e-05	0.000507	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	3.03e-05	0.000502	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—PLA2G1B—atherosclerosis	3.01e-05	0.000498	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—PPARA—atherosclerosis	2.98e-05	0.000494	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—VEGFA—atherosclerosis	2.94e-05	0.000487	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	2.91e-05	0.000483	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—STAT3—atherosclerosis	2.91e-05	0.000482	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—ABCG1—atherosclerosis	2.91e-05	0.000482	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—ALOX5—atherosclerosis	2.9e-05	0.000481	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—LDLRAP1—atherosclerosis	2.88e-05	0.000477	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—IL6—atherosclerosis	2.85e-05	0.000472	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	2.81e-05	0.000467	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—APOA1—atherosclerosis	2.79e-05	0.000463	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—MAPK3—atherosclerosis	2.78e-05	0.000461	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—FABP4—atherosclerosis	2.74e-05	0.000454	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—LCAT—atherosclerosis	2.74e-05	0.000454	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PLTP—atherosclerosis	2.71e-05	0.000449	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—TGFB1—atherosclerosis	2.7e-05	0.000447	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—APOA4—atherosclerosis	2.69e-05	0.000445	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—CYP7A1—atherosclerosis	2.64e-05	0.000437	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—NAMPT—atherosclerosis	2.61e-05	0.000432	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—LIPC—atherosclerosis	2.59e-05	0.000429	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—APOC3—atherosclerosis	2.57e-05	0.000426	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—LDLR—atherosclerosis	2.56e-05	0.000424	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—TNF—atherosclerosis	2.52e-05	0.000418	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	2.51e-05	0.000417	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	2.51e-05	0.000416	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—CETP—atherosclerosis	2.5e-05	0.000414	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	2.49e-05	0.000413	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	2.48e-05	0.000411	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—CYP27A1—atherosclerosis	2.44e-05	0.000404	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	2.42e-05	0.000401	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	2.4e-05	0.000398	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—SCARB1—atherosclerosis	2.39e-05	0.000396	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—LTA4H—atherosclerosis	2.35e-05	0.000389	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ABCG8—atherosclerosis	2.35e-05	0.000389	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	2.34e-05	0.000388	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	2.32e-05	0.000384	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—ALOX15—atherosclerosis	2.31e-05	0.000383	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—ALOX5AP—atherosclerosis	2.31e-05	0.000383	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—APOA2—atherosclerosis	2.31e-05	0.000383	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PLA2G2A—atherosclerosis	2.31e-05	0.000383	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—ABCG5—atherosclerosis	2.28e-05	0.000379	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	2.28e-05	0.000378	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—HMGCR—atherosclerosis	2.26e-05	0.000374	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—ALB—atherosclerosis	2.21e-05	0.000367	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—LPA—atherosclerosis	2.21e-05	0.000366	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	2.19e-05	0.000363	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—BGN—atherosclerosis	2.14e-05	0.000354	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	2.12e-05	0.000352	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—APOA5—atherosclerosis	2.11e-05	0.000351	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	2.05e-05	0.00034	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PLA2G1B—atherosclerosis	2.04e-05	0.000337	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—IL6—atherosclerosis	2.03e-05	0.000337	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—ABCA1—atherosclerosis	2.01e-05	0.000334	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	2.01e-05	0.000334	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.99e-05	0.000331	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.99e-05	0.00033	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—ALOX5—atherosclerosis	1.97e-05	0.000326	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	1.95e-05	0.000323	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—AKT1—atherosclerosis	1.88e-05	0.000311	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ABCG1—atherosclerosis	1.86e-05	0.000308	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.82e-05	0.000301	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—NAMPT—atherosclerosis	1.76e-05	0.000292	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.75e-05	0.000291	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—LIPC—atherosclerosis	1.75e-05	0.00029	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—LCAT—atherosclerosis	1.74e-05	0.000289	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—FABP4—atherosclerosis	1.74e-05	0.000289	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—APOC3—atherosclerosis	1.74e-05	0.000289	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—LDLR—atherosclerosis	1.73e-05	0.000287	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—HMOX1—atherosclerosis	1.73e-05	0.000286	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—APOA4—atherosclerosis	1.71e-05	0.000284	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—CETP—atherosclerosis	1.69e-05	0.00028	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CYP7A1—atherosclerosis	1.68e-05	0.000279	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—APOB—atherosclerosis	1.65e-05	0.000274	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—SCARB1—atherosclerosis	1.62e-05	0.000268	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—GSTM1—atherosclerosis	1.61e-05	0.000267	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	1.6e-05	0.000266	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—LPL—atherosclerosis	1.58e-05	0.000262	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.58e-05	0.000261	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CYP27A1—atherosclerosis	1.56e-05	0.000258	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—GPX1—atherosclerosis	1.54e-05	0.000255	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	1.53e-05	0.000254	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—HMGCR—atherosclerosis	1.53e-05	0.000253	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—CD36—atherosclerosis	1.5e-05	0.000249	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1.49e-05	0.000248	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ALOX15—atherosclerosis	1.47e-05	0.000244	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—APOA2—atherosclerosis	1.47e-05	0.000244	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ALOX5AP—atherosclerosis	1.47e-05	0.000244	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PLA2G2A—atherosclerosis	1.47e-05	0.000244	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ABCG5—atherosclerosis	1.46e-05	0.000241	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.45e-05	0.000241	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—MTHFR—atherosclerosis	1.42e-05	0.000236	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—LPA—atherosclerosis	1.41e-05	0.000233	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—PPARA—atherosclerosis	1.4e-05	0.000231	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.38e-05	0.000229	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—ABCA1—atherosclerosis	1.36e-05	0.000226	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—BGN—atherosclerosis	1.36e-05	0.000226	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.35e-05	0.000224	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—AGT—atherosclerosis	1.35e-05	0.000224	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—APOA5—atherosclerosis	1.35e-05	0.000223	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—APOE—atherosclerosis	1.32e-05	0.000219	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—CAV1—atherosclerosis	1.31e-05	0.000217	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.31e-05	0.000217	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—APOA1—atherosclerosis	1.31e-05	0.000217	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PLA2G1B—atherosclerosis	1.3e-05	0.000215	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.28e-05	0.000213	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.27e-05	0.000211	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.27e-05	0.00021	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ALOX5—atherosclerosis	1.25e-05	0.000208	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—PIK3CG—atherosclerosis	1.2e-05	0.000198	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—HMOX1—atherosclerosis	1.17e-05	0.000194	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.16e-05	0.000192	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—PPARG—atherosclerosis	1.15e-05	0.000191	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—INS—atherosclerosis	1.13e-05	0.000187	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—NAMPT—atherosclerosis	1.12e-05	0.000186	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—APOB—atherosclerosis	1.12e-05	0.000186	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.12e-05	0.000185	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—LIPC—atherosclerosis	1.12e-05	0.000185	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—APOC3—atherosclerosis	1.11e-05	0.000184	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—LDLR—atherosclerosis	1.1e-05	0.000183	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—GSTM1—atherosclerosis	1.09e-05	0.000181	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CETP—atherosclerosis	1.08e-05	0.000179	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—LPL—atherosclerosis	1.07e-05	0.000177	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—GPX1—atherosclerosis	1.04e-05	0.000173	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—ALB—atherosclerosis	1.04e-05	0.000172	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—SCARB1—atherosclerosis	1.03e-05	0.000171	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—CD36—atherosclerosis	1.02e-05	0.000168	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.01e-05	0.000167	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—NOS3—atherosclerosis	9.92e-06	0.000164	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—HMGCR—atherosclerosis	9.75e-06	0.000162	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—MTHFR—atherosclerosis	9.63e-06	0.00016	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PPARA—atherosclerosis	9.45e-06	0.000157	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—AGT—atherosclerosis	9.15e-06	0.000152	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—PTGS2—atherosclerosis	9.07e-06	0.00015	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—APOE—atherosclerosis	8.96e-06	0.000149	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—CAV1—atherosclerosis	8.88e-06	0.000147	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—APOA1—atherosclerosis	8.86e-06	0.000147	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	8.79e-06	0.000146	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ABCA1—atherosclerosis	8.69e-06	0.000144	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PIK3CG—atherosclerosis	8.09e-06	0.000134	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PPARG—atherosclerosis	7.81e-06	0.000129	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—INS—atherosclerosis	7.66e-06	0.000127	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—HMOX1—atherosclerosis	7.45e-06	0.000124	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—APOB—atherosclerosis	7.14e-06	0.000118	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—ALB—atherosclerosis	7.02e-06	0.000116	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—GSTM1—atherosclerosis	6.95e-06	0.000115	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—LPL—atherosclerosis	6.82e-06	0.000113	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—NOS3—atherosclerosis	6.72e-06	0.000111	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—GPX1—atherosclerosis	6.65e-06	0.00011	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CD36—atherosclerosis	6.48e-06	0.000107	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PTGS2—atherosclerosis	6.14e-06	0.000102	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—MTHFR—atherosclerosis	6.14e-06	0.000102	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PPARA—atherosclerosis	6.02e-06	9.98e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—AGT—atherosclerosis	5.83e-06	9.67e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—APOE—atherosclerosis	5.72e-06	9.47e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CAV1—atherosclerosis	5.66e-06	9.39e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—APOA1—atherosclerosis	5.65e-06	9.36e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PIK3CG—atherosclerosis	5.16e-06	8.55e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PPARG—atherosclerosis	4.98e-06	8.25e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—INS—atherosclerosis	4.88e-06	8.09e-05	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—AKT1—atherosclerosis	4.56e-06	7.56e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ALB—atherosclerosis	4.48e-06	7.42e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—NOS3—atherosclerosis	4.28e-06	7.1e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PTGS2—atherosclerosis	3.92e-06	6.49e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—AKT1—atherosclerosis	3.09e-06	5.12e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—AKT1—atherosclerosis	1.97e-06	3.26e-05	CbGpPWpGaD
